Mireille N. Bekker

ORCID: 0000-0002-7372-4291
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prenatal Screening and Diagnostics
  • Fetal and Pediatric Neurological Disorders
  • Pregnancy and preeclampsia studies
  • Maternal and fetal healthcare
  • Maternal and Perinatal Health Interventions
  • Parvovirus B19 Infection Studies
  • Neonatal Respiratory Health Research
  • Birth, Development, and Health
  • Pediatric Urology and Nephrology Studies
  • Congenital Diaphragmatic Hernia Studies
  • Gestational Diabetes Research and Management
  • Renal and related cancers
  • Congenital Anomalies and Fetal Surgery
  • Assisted Reproductive Technology and Twin Pregnancy
  • Preterm Birth and Chorioamnionitis
  • Cardiovascular Issues in Pregnancy
  • Urological Disorders and Treatments
  • Pregnancy-related medical research
  • Congenital heart defects research
  • Ethics and Legal Issues in Pediatric Healthcare
  • Maternal Mental Health During Pregnancy and Postpartum
  • Neonatal and fetal brain pathology
  • Congenital Heart Disease Studies
  • Bacterial Infections and Vaccines
  • Vaccine Coverage and Hesitancy

University Medical Center Utrecht
2016-2025

Utrecht University
2016-2025

Wilhelmina Children's Hospital
2016-2025

University Medical Center
2019-2024

National Institute for Public Health and the Environment
2023

Vrije Universiteit Amsterdam
2001-2023

Erasmus MC
2019-2023

Erasmus University Rotterdam
2023

Amsterdam University Medical Centers
2023

University Hospital Heidelberg
2016-2020

The Netherlands launched a nationwide implementation study on non-invasive prenatal testing (NIPT) as first-tier test offered to all pregnant women. This started April 1, 2017 the TRIDENT-2 study, licensed by Dutch Ministry of Health. In first year, NIPT was performed in 73,239 pregnancies (42% pregnancies), 7,239 (4%) chose first-trimester combined testing, and 54% did not participate. number trisomies 21 (239, 0.33%), 18 (49, 0.07%), 13 (55, 0.08%) found this is comparable earlier studies,...

10.1016/j.ajhg.2019.10.005 article EN publisher-specific-oa The American Journal of Human Genetics 2019-11-07

Objective To evaluate the clinical impact of nationwide implementation genome-wide non-invasive prenatal testing (NIPT) in pregnancies at increased risk for fetal trisomies 21, 18 and 13 (TRIDENT study). Method Women with elevated based on first trimester combined (FCT ≥ 1:200) or medical history, not advanced maternal age alone, were offered NIPT as contingent screening test, performed by Dutch University Medical laboratories. We analyzed uptake, test performance, redraw/failure rate,...

10.1002/pd.4945 article EN cc-by-nc-nd Prenatal Diagnosis 2016-10-17

In the TRIDENT-2 study, all pregnant women in Netherlands are offered genome-wide non-invasive prenatal testing (GW-NIPT) with a choice of receiving either full screening or solely for common trisomies. Previous data showed that GW-NIPT can reliably detect trisomies general obstetric population and this test also other chromosomal abnormalities (additional findings). However, evidence regarding clinical impact additional findings is lacking. Therefore, we present follow-up results study to...

10.1016/j.ajhg.2022.04.018 article EN cc-by-nc-nd The American Journal of Human Genetics 2022-06-01
Ingrid M. Bistervels Andréa Buchmuller Hanke M.G. Wiegers Fionnuala Ní Áinle Bernard Tardy and 95 more Jennifer Donnelly Peter Verhamme Anne Flem Jacobsen Anette Tarp Hansen Marc Rodger Maria T. DeSancho R.G. Shmakov Nick van Es Martin H. Prins Céline Chauleur Saskia Middeldorp Eline S. van den Akker Mireille N. Bekker Thomas van Bemmel Laurent Bertoletti Julie Blanc Suzanne M. Bleker Aude Bourtembourg-Matras Florence Bretelle B. Byrne Françis Couturaud Pierre Delorme Elise S. Eerenberg Maureen TM Franssen Jens Fuglsang Wessel Ganzevoort François Goffinet Jiska M de Haan-Jebbink Wieteke M. Heidema Monique A Hertzberg Marcel M.C. Hovens Menno V. Huisman Leonie de Jong-Speksnijder Pieter W. Kamphuisen Denis J O'Keeffe Karine Lacut Josje Langenveld M Simone Lunshof Caroline P. Martens A. Merah Emmanuelle Le Moigne Dimitri N.M. Papatsonis Gilles Pernod F. Perrotin Edith Peynaud-Debayle Fabrice Pierre Geneviève Bureau Tiphaïne Raia-Barjat Robbert JP Rijnders Roger Rosario M. Ruivard Jeannot Schmidt Marieke Sueters Thomas Vanassche Marie-Noëlle Varlet Alexandre J. Vivanti Matthieu Y. van der Vlist Lucet F. van der Voet Karlijn C. Vollebregt Johanna I. de Vries Sabina de Weerd Peter E. Westerweel Lia DE Wijnberger Marije ten Wolde Paula F. Ypma Catherine Zuily-Lamy Joost J. Zwart Alexandra Benachi G. Beucher H. Bézanahary Karin Boer Marjon A. de Boer Frantz Bousquet Henk A. Bremer Luc Bressollette Aurélie Brossard C. Chau Brian Cleary Fabienne Comte Thomas Corsini Anne Coustel Barbara Debaveye Raoul Desbrière Cécile Duvillard A. Eckman Jeroen Eikenboom Antoine Élias Laura M. Faber Émile Ferrari Denis Gallot Emilie Gauchotte Ingrid Gaugler Abby E. Geerlings Audrey O'Gorman Vincent Grobost

10.1016/s0140-6736(22)02128-6 article EN The Lancet 2022-10-28

Women with complicated pregnancies often require hospital admission. Telemonitoring at home is a promising alternative that fulfils worldwide need in obstetric health care. Moreover, the COVID-19 pandemic has accelerated transformation to digital The aim of this study was evaluate safety, clinical effectiveness, patient satisfaction, and costs telemonitoring against care pregnancies.

10.1016/s2589-7500(22)00231-x article EN cc-by The Lancet Digital Health 2023-02-22

Abstract Objectives To give an overview of the genetic and structural abnormalities occurring in fetuses with nuchal translucency (NT) measurement exceeding 95th percentile at first‐trimester screening to investigate which these would be missed if cell‐free fetal DNA (cfDNA) were used as a first‐tier test for chromosomal abnormalities. Methods This is national study including 1901 pregnancies NT≥95th referred seven university hospitals Netherlands between 1 January 2010 2016. All cases...

10.1002/pd.5590 article EN cc-by-nc-nd Prenatal Diagnosis 2019-11-07

ABSTRACT Objective Fetal megacystis presents a challenge in terms of counseling and management because its varied etiology evolution. The aim this study was to present comprehensive overview the underlying etiologies structural anomalies associated with fetal megacystis. Methods This retrospective multicenter cases referred medicine unit one eight academic hospitals Netherlands diagnosis For each case, data on measurements urinary tract were collected. All available postmortem examinations...

10.1002/uog.19182 article EN cc-by-nc Ultrasound in Obstetrics and Gynecology 2018-07-25

To evaluate the application of non-invasive prenatal testing (NIPT) as an alternative to invasive diagnostic in pregnancies with abnormal ultrasound findings.This was a retrospective analysis 251 singleton and multiple at high risk for fetal chromosomal abnormality based on findings sonographic examination, which NIPT performed first-tier genetic test. by massively parallel sequencing cell-free DNA maternal plasma, allowing genome-wide detection whole-chromosome, well partial, autosomal...

10.1002/uog.17228 article EN cc-by-nc-nd Ultrasound in Obstetrics and Gynecology 2016-08-12

Hospital admission during pregnancy complications is considered to be an event of significant impact. Besides conventional in-clinic maternal and fetal monitoring, recent technologies enable home-based telemonitoring with self-measurements in high risk pregnancy. This study part a feasibility pilot explore the usability acceptability aims gain insight experiences preferences pregnant women concerning novel strategy telemonitoring, opposed who were hospitalized pregnancy.Using secured...

10.1186/s12884-020-2779-4 article EN cc-by BMC Pregnancy and Childbirth 2020-02-04

In women at risk of developing preeclampsia, we evaluated the use a digital health platform for telemonitoring blood pressure and symptoms combined with minimal antenatal visit schedule. A case-control study chronic hypertension, history or maternal cardiac kidney disease. care path was designed reduced visits enhanced ([email protected]) daily symptom monitoring starting from 16 weeks gestation. Home-measurements were monitored in-hospital by obstetric professionals, taking actions upon...

10.1016/j.preghy.2020.07.006 article EN cc-by Pregnancy Hypertension 2020-07-18

Noninvasive prenatal testing by cell-free DNA analysis is offered to pregnant women worldwide screen for fetal aneuploidies. In noninvasive testing, the fraction of in maternal circulation measured as a quality control parameter. Given that originates from placenta, might also reflect placental health and pregnancy adaptation.

10.1016/j.ajog.2023.12.008 article EN cc-by American Journal of Obstetrics and Gynecology 2023-12-12

This study evaluates pregnant women's and healthcare professionals' preferences regarding specific prenatal screening diagnostic test characteristics.A discrete choice experiment was developed to assess for tests that differed in seven attributes: minimal gestational age, time results, level of information, detection rate, false positive miscarriage risk costs.The questionnaire completed by 596 (70.2%) women 297 (51.7%) professionals, whom 507 (85.1%) 283 (95.3%), respectively, were included...

10.1002/pd.4571 article EN Prenatal Diagnosis 2015-02-02

Abstract Sex differences in endothelial cell (EC) biology may reflect intrinsic driven by chromosomes or sex steroid exposure and gender accumulated over life. We analysed EC gene expression data from boy–girl twins at birth non-twin adults to detect different stages of life, show that 14–25% the transcriptome is sex-biased. By combining both we identified are present maintained throughout those acquired Promisingly, found genes with an difference ECs more likely be targets steroids....

10.1038/s41598-020-69451-8 article EN cc-by Scientific Reports 2020-07-23

ABSTRACT Objective To propose a staging system for congenital lower urinary tract obstruction (LUTO) capable of predicting the severity condition and its prognosis. Methods This was national retrospective study carried out at eight Academic Hospitals in The Netherlands. We collected prenatal postnatal data fetuses high risk isolated LUTO that were managed conservatively. Postnatal renal function assessed by estimated glomerular filtration rate (eGFR), calculated using Schwartz formula,...

10.1002/uog.19172 article EN Ultrasound in Obstetrics and Gynecology 2018-07-06

To develop a nationwide, evidence-based framework to support prenatal counseling in extreme prematurity, focusing on organization, decision-making, content, and style aspects.A nationwide multicenter RAND-modified Delphi method study was performed between November 2016 December 2017 the Netherlands. Firstly, recommendations were extracted from literature previous studies. Secondly, an expert panel (n = 21) with experienced parents, obstetricians, neonatologists rated importance for inclusion...

10.1542/peds.2018-3253 article EN PEDIATRICS 2019-05-31
Coming Soon ...